These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15647716)

  • 1. Advances in diabetes for the millennium: understanding insulin resistance.
    Gerich JE; Dailey G
    MedGenMed; 2004 Aug; 6(3 Suppl):11. PubMed ID: 15647716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.
    Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of type 2 diabetes mellitus.
    Dostou J; Gerich J
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S149-56. PubMed ID: 11460566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is insulin resistance the principal cause of type 2 diabetes?
    Gerich JE
    Diabetes Obes Metab; 1999 Sep; 1(5):257-63. PubMed ID: 11225637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance.
    Bardini G; Dicembrini I; Pala L; Cresci B; Rotella CM
    Diabet Med; 2011 Oct; 28(10):1229-33. PubMed ID: 21923697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.
    Groop L
    Int J Clin Pract Suppl; 2000 Oct; (113):3-13. PubMed ID: 11965829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone and sulfonylureas: effectively treating type 2 diabetes.
    Hanefeld M
    Int J Clin Pract Suppl; 2007 Jun; 61(153):20-7. PubMed ID: 17594390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Gastaldelli A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S60-5. PubMed ID: 21864753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of type 2 diabetes mellitus].
    Guillausseau PJ; Laloi-Michelin M
    Rev Med Interne; 2003 Nov; 24(11):730-7. PubMed ID: 14604750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study.
    Ohn JH; Kwak SH; Cho YM; Lim S; Jang HC; Park KS; Cho NH
    Lancet Diabetes Endocrinol; 2016 Jan; 4(1):27-34. PubMed ID: 26577716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can thiazolidinediones delay disease progression in type 2 diabetes?
    Leiter LA
    Curr Med Res Opin; 2006 Jun; 22(6):1193-201. PubMed ID: 16846552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
    Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
    Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG; Owusu SK; Schuster DP; Osei K
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-cell function and anti-diabetic pharmacotherapy.
    Del Prato S; Bianchi C; Marchetti P
    Diabetes Metab Res Rev; 2007 Oct; 23(7):518-27. PubMed ID: 17883249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.